Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H23Cl2FN4O4 |
InChIKeyYZMITHOPDOPJBH-HLNVOFQHSA-N |
CAS Registry1883383-48-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | Germany | - |